National Allergy Research Center, Denmark
7
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Contact Allergy to Rubber Accelerators - a Clinical Study
Role: lead
Detection of Aluminium-reactive T-lymphocytes in Patients With Vaccination Granulomas
Role: lead
Occupational Hand Eczema - Testing of a Prevention-concept
Role: lead
Repeated Open Application Test (ROAT) Study With Hydroperoxides of Linalool
Role: lead
Children With Aluminium Contact Allergy: Oral Exposure Study
Role: lead
The Immunological Profile of Nickel Dermatitis
Role: lead
Children With Aluminium Contact Allergy: Cutaneous Exposure Study
Role: lead
All 7 trials loaded